Literature DB >> 33738766

In-hospital opioid usage following posterior spinal fusion for adolescent idiopathic scoliosis: Does methadone offer an advantage when used with an ERAS pathway?

K Aaron Shaw1, Nicholas D Fletcher2, Dennis P Devito3, Michael L Schmitz3, Jorge Fabregas3, Simran Gidwani3, Pankaj Chhatbar4, Joshua S Murphy3.   

Abstract

PURPOSE: Intraoperative methadone has been shown to decrease opioid medication requirement following posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS). No study to date has investigated the effect of methadone on opioid medication requirement when used in conjunction with an enhanced recovery after surgery (ERAS) protocol following PSF.
METHODS: A retrospective cohort study was performed at a single, tertiary care pediatric hospital. Patients with AIS undergoing PSF were consecutively given a single intra-operative methadone dose and matched 1:2 to a AIS control group without methadone. Patients were matched for age, curve magnitude, levels fused, blood loss, and operating time. All children followed a standard ERAS protocol with methadone being the only change in the post-operative regimen. In-hospital data for opioid and non-opioid medication use, surgical, and patient variables were recorded and compared between cohorts.
RESULTS: Twenty-six patients received methadone (average 15.1 ± 1.9 years) and were matched with 52 control patients without methadone (average 14.7 ± 2.2 years). There were no significant differences in total opioid usage at any time-interval prior to hospital discharge or in cumulative opioid usage. Additionally, patients had a similar VAS pain level at discharge (methadone: 4.0 ± 2.3 vs control: 3.8 ± 1.9; P = 0.572). Total opioid usage was correlated with LOS. There were no opioid-related medication complications in either cohort.
CONCLUSION: There was no decrease of in-hospital opioid usage when methadone was used with an ERAS protocol. Total opioid usage is correlated with hospital LOS following PSF.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Adolescent idiopathic scoliosis; ERAS; Methadone; Opioid; Posterior spinal fusion

Year:  2021        PMID: 33738766     DOI: 10.1007/s43390-021-00288-5

Source DB:  PubMed          Journal:  Spine Deform        ISSN: 2212-134X


  2 in total

1.  Risk Factors for Prolonged Postoperative Opioid Use After Spinal Fusion for Adolescent Idiopathic Scoliosis.

Authors:  Scott Yang; Brian C Werner
Journal:  J Pediatr Orthop       Date:  2019 Nov/Dec       Impact factor: 2.324

2.  Rapid Recovery Pathway After Spinal Fusion for Idiopathic Scoliosis.

Authors:  Wallis T Muhly; Wudbhav N Sankar; Kelly Ryan; Annette Norton; Lynne G Maxwell; Theresa DiMaggio; Sharon Farrell; Rachel Hughes; Alex Gornitzky; Ron Keren; John J McCloskey; John M Flynn
Journal:  Pediatrics       Date:  2016-03-23       Impact factor: 7.124

  2 in total
  2 in total

1.  Continued Increase in Cost of Care Despite Decrease in Stay After Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis.

Authors:  K Aaron Shaw; Brittany Ange; Varghese George; Joshua S Murphy; Nicholas D Fletcher
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-03-11

Review 2.  Key Components, Current Practice and Clinical Outcomes of ERAS Programs in Patients Undergoing Orthopedic Surgery: A Systematic Review.

Authors:  Francesca Salamanna; Deyanira Contartese; Silvia Brogini; Andrea Visani; Konstantinos Martikos; Cristiana Griffoni; Alessandro Ricci; Alessandro Gasbarrini; Milena Fini
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.